By Natalie GroverREUTERS - Thermo Fisher Scientific Inc said on Monday it would buy Dutch drug ingredients maker Patheon NV, as it looks to become a one-stop shop for contract drug development and manufacturing.The offer price of $35 per share represents a premium of about 35 percent to Patheon's Friday close. Patheon's shares were trading at $34.60, just shy of the offer.Thermo Fisher, the world's No. 1 maker of scientific instruments, provides research, clinical trial and production services to the biopharmaceutical industry. Patheon offers a broad range of services from regulatory ...
Thermo Fisher to buy drug ingredients maker Patheon for $5.2 billion
Reuters Last Updated at May 15, 2017 19:49 IST
First Published: Mon, May 15 2017. 19:31 IST
This article is no longer available in our repository.
There could be multiple reasons for this.
You could try searching for this headline on the source website (reuters.com).